Shanxi Huanghe Traditional Chinese Medicine Research Institute

Shanxi Huanghe Traditional Chinese Medicine Research Institute (also known as Shanxi Huanghe Institute of Traditional Chinese Medicine) is a Chinese pharmaceutical research organization and subsidiary of Shanxi Huanghe Traditional Chinese Medicine Co., Ltd. (Yi Sheng Tang). Founded in 2003 and based in Jinzhong, Shanxi, the institute focuses on the modernization, inheritance, and development of traditional Chinese medicine (TCM). It specializes in researching ancient classic formulas, developing modern TCM dosage forms (such as soft capsules and granules), and conducting clinical trials for new botanical drugs. The institute's pipeline includes advanced candidates like Shanjinlian Soft Capsules and Zhengqi Xiaoshu Soft Capsules, which are currently in Phase 3 clinical development for respiratory and seasonal indications.